AboutSign In

Nivolumab

Product

Checkpoint inhibitor immunotherapy drug marketed as Opdivo by Bristol Myers Squibb

1 story

01
health1h ago

White House Intervention Gave Replimune Cancer Drug a Third Chance After Two FDA Rejections

11 min read